Human anti-IFN-gamma neutralizing antibodies as selective IFN-gamma pathway inhibitors

Details for Australian Patent Application No. 2003286437 (hide)

International Classifications

Event Publications

1 April 2004 Complete Application Filed

Priority application(s): 60/479,241 17.06.03 US; 60/419,057 16.10.02 US

10 June 2004 Application Open to Public Inspection

Published as AU-B-2003286437

28 April 2005 Amendment Made

The nature of the amendment is: Delete co-applicant Medarex, Inc.

27 April 2006 Change of Name(s) of Applicant(s), Section 104

Amgen Inc., Has no value - Entry Incomplete The name of the applicant has been changed to Medarex, Inc.; Amgen Inc.

13 March 2008 Application Accepted

Published as AU-B-2003286437

10 July 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.